Onconetix, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$25M
↓-11.5% -$3Mvs FY2024
Total Liabilities
$9M
↓-50.7% -$9Mvs FY2024
Equity
$16M
↑+84.5% +$7Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $25M | $28M |
| Current Assets | $6M | $950K |
| Cash | $0 | $0 |
| ST Investments | $0 | $0 |
| Receivables | $297K | $26K |
| Inventory | $150K | $64K |
| Other Current | $6M | $860K |
| Non-Current Assets | $19M | $27M |
| PPE | $37K | $63K |
| Goodwill | $19M | $27M |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $274K | $119K |
| Total Liab+Eq | $25M | $27M |
| Current Liab. | $9M | $18M |
| Accounts Payable | $2M | $4M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $7M | $15M |
| Non-Current Liab. | $24K | $281K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $24K | $281K |
| Equity | $16M | $9M |
| Retained Earnings | $131M | $116M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · ONCO · Comparing FY2025 vs FY2024